Targeted oncogene activation by site-specific recombination in transgenic mice - PubMed (original) (raw)

Targeted oncogene activation by site-specific recombination in transgenic mice

M Lakso et al. Proc Natl Acad Sci U S A. 1992.

Abstract

An efficient and accurate method for controlled in vivo transgene modulation by site-directed recombination is described. Seven transgenic mouse founder lines were produced carrying the murine lens-specific alpha A-crystallin promoter and the simian virus 40 large tumor-antigen gene sequence, separated by a 1.3-kilobase-pair Stop sequence that contains elements preventing expression of the large tumor-antigen gene and Cre recombinase recognition sites. Progeny from two of these lines were mated with transgenic mice expressing the Cre recombinase under control of either the murine alpha A-crystallin promoter or the human cytomegalovirus promoter. All double-transgenic offspring developed lens tumors. Subsequent analysis confirmed that tumor formation resulted from large tumor-antigen activation via site-specific, Cre-mediated deletion of Stop sequences.

PubMed Disclaimer

References

    1. New Biol. 1989 Nov;1(2):193-204 - PubMed
    1. Genome. 1989;31(2):520-7 - PubMed
    1. Science. 1991 Mar 15;251(4999):1351-5 - PubMed
    1. Crit Rev Biochem Mol Biol. 1990;25(6):415-56 - PubMed
    1. Cell. 1989 Nov 3;59(3):499-509 - PubMed

MeSH terms

Substances

LinkOut - more resources